Eun-Wook Choi
Chief Executive Officer bei SPHERE POWER INC.
Profil
Eun-Wook Choi is currently the Co-Chief Executive Officer & Director at Sphere Power, Inc. He previously worked as a Director at KB No.
3 Special Purpose Acquisition Co. He holds a doctorate degree from Seoul National University and undergraduate and graduate degrees from Sogang University.
Aktive Positionen von Eun-Wook Choi
| Unternehmen | Position | Beginn |
|---|---|---|
| SPHERE POWER INC. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Eun-Wook Choi
| Unternehmen | Position | Ende |
|---|---|---|
KB No. 3 Special Purpose Acquistion Co.
 KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Director/Board Member | - |
Ausbildung von Eun-Wook Choi
| Seoul National University | Doctorate Degree |
| Sogang University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SPHERE POWER INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
KB No. 3 Special Purpose Acquistion Co.
KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Finance |
